TP53 and colorectal carcinoma: In addition, studies have found that Circ-GALNT16 inhibits the progression of CRC by regulating the sequence-specific DNA binding capacity of the hnRNPK-p53 transcription complex mediated by SENP2 to inhibit Serpine1 expression [22].